Search results
Results From The WOW.Com Content Network
Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure.
This list was last comprehensively updated in September 2021. It is likely to become outdated with time. ... Guanfacine (Connexyn, Intuniv, Intuniv XR, Tenex) [140 ...
Intuniv - an extended release, non-stimulant alpha-2 adrenergic agonist used to treat attention deficit hyperactivity disorder. Available in instant-release under the brand-name Tenex . Invega ( paliperidone ) – atypical antipsychotic used to treat schizophrenia and schizoaffective disorder
[46] [51] [53] Lisdexamfetamine is an inactive prodrug of dextroamphetamine (i.e., lisdexamfetamine itself does not do anything in the body, but it metabolizes into dextroamphetamine). [46] Adderall is a proprietary mixture of (75%) dextroamphetamine and (25%) levoamphetamine salts, which results in very mild differences between their effects. [46]
Intuniv, Tenex Modafinil: Provigil, Alertec, Modavigil Armodafinil: Nuvigil Anxiety Disorders ... This page was last edited on 29 August 2024, at 02:50 (UTC).
The slow and long-acting nonstimulant atomoxetine (Strattera), is primarily a norepinephrine reuptake inhibitor and, to a lesser extent, a dopamine reuptake inhibitor. [14] It is sometimes prescribed in adults who do not get enough vigilant concentration response from mixed amphetamine salts (Adderall) or get too many side effects.
A 2003 study found that non-prescription use within the last year by college students in the US was 4.1%. [104] A 2008 meta-analysis found even higher rates of non-prescribed stimulant use. It found 5% to 9% of grade school and high school children and 5% to 35% of college students used a non-prescribed stimulant in the last year. [102]
Cognitive disengagement syndrome (CDS) is a syndrome characterized by developmentally inappropriate, impairing, and persistent levels of decoupled attentional processing from the ongoing external context and resultant hypoactivity.